Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N MAini

Showing results (231-240 of 257) with videos related to

Pageof 26
Sort By:
The Journal of Clinical Investigation|August 1, 1994
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritisA P Cope, M Londei, N R Chu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipramS E Ross, R O Williams, L J Mason, et al.
Annals of the Rheumatic Diseases|August 1, 1986
HLA and rheumatoid arthritis: a combined analysis of 440 British patientsD Jaraquemada, W Ollier, J Awad, et al.
Immunology|April 1, 1983
In vivo fate of 125I SS-B (La) injected into miceL Schrieber, C C Erhardt, R D Melsom, et al.
British Journal of Rheumatology|November 1, 1992
The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune diseaseS M Brookes, Y A Pandolfino, T J Mitchell, et al.
Developments in Biologicals|May 24, 2003
Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and RemicadeC L Wagner, A Schantz, E Barnathan, et al.
Arthritis and Rheumatism|December 1, 1993
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alphaM J Elliott, R N Maini, M Feldmann, et al.
Arthritis and Rheumatism|October 1, 1992
Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseasesA P Cope, D Aderka, M Doherty, et al.
Arthritis and Rheumatism|July 1, 1996
Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritisP P Tak, P C Taylor, F C Breedveld, et al.
Immunological Reviews|April 1, 1995
Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid diseaseR N Maini, M J Elliott, F M Brennan, et al.
Pageof 26

Showing results (231-240 of 257) with videos related to

Sort By:
Pageof 26
The Journal of Clinical Investigation|August 1, 1994
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritisA P Cope, M Londei, N R Chu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipramS E Ross, R O Williams, L J Mason, et al.
Annals of the Rheumatic Diseases|August 1, 1986
HLA and rheumatoid arthritis: a combined analysis of 440 British patientsD Jaraquemada, W Ollier, J Awad, et al.
Immunology|April 1, 1983
In vivo fate of 125I SS-B (La) injected into miceL Schrieber, C C Erhardt, R D Melsom, et al.
British Journal of Rheumatology|November 1, 1992
The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune diseaseS M Brookes, Y A Pandolfino, T J Mitchell, et al.
Developments in Biologicals|May 24, 2003
Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and RemicadeC L Wagner, A Schantz, E Barnathan, et al.
Arthritis and Rheumatism|December 1, 1993
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alphaM J Elliott, R N Maini, M Feldmann, et al.
Arthritis and Rheumatism|October 1, 1992
Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseasesA P Cope, D Aderka, M Doherty, et al.
Arthritis and Rheumatism|July 1, 1996
Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritisP P Tak, P C Taylor, F C Breedveld, et al.
Immunological Reviews|April 1, 1995
Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid diseaseR N Maini, M J Elliott, F M Brennan, et al.
Pageof 26